Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors

Cytotherapy

Volumn 3, Issue 5, 2001, Pages 361-364

  McGuire, T R ^a   Kessinger, A ^b   Hock, L ^c   Sharp, J G ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Hematopoietic stem cells; Mobilization; TGF

Indexed keywords

CD34 ANTIGEN; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA;

ALLOTRANSPLANTATION; APHERESIS; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; BLOOD CELL COUNT; BLOOD DONOR; BLOOD SAMPLING; CANCER; CANCER PATIENT; CLINICAL ARTICLE; COLONY FORMING UNIT GM; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PLASMA; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION; STUDENT T TEST; BLOOD; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; METABOLISM; NEOPLASM; NONHODGKIN LYMPHOMA; PATHOLOGY;

ANTIGENS, CD34; BLOOD DONORS; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035527585     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532401753277652     Document Type: Article

References (13)

1. Factors that influence collection and engraftment of autologous peripheral-blood stem cells
2. The effect of bone marrow metastasis and prior treatments on progenitor cell content of blood stem cell harvests in breast cancer patients
3. Concurrent partial body irradiation prevents cytokine mobilization of blood progenitor cells: An effect mediated by a circulating factor
4. Transforming growth factor β directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells
5. Transforming growth factor β selectively inhibits normal and leukemic human bone marrow cell growth in vitro
6. A subset of metastatic human colon cancers express elevated levels of transforming growth factor beta1
7. Transforming growth factor-beta in benign and malignant prostate
8. Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer
9. Transforming growth factor-β and its receptors
10. Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid and thrombocytic cells in mice
11. Inhibition of endogenous transforming growth factor beta-1 in long term repopulating hematopoietic stem cells by morpholino antisense oligo-nucleotides (MAS) prior to transplant accelerates engraftment while reducing the number of stem cells required for long-term repopulation
12. Dose-dependent induction of transforming growth factor beta in the lung tissue of fibrosis-prone mice after thoracic irradiation
13. Elevated levels of plasma transforming growth factor-beta in patients with hepatocellular carcinoma